Anticoagulants in heart disease.
Vine
D L
DL
Department of Medicine, University of Kansas School of Medicine-Wichita 67214.
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D001777:Blood Coagulation / Q000187:drug effects; D002311:Cardiomyopathy, Dilated / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D003327:Coronary Disease / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D006331:Heart Diseases / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D013923:Thromboembolism / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D006493:Heparin